The newly-founded Oxford cardiovascular imaging spinout raised seed funding from backers including Oxford Sciences Innovation to pursue further product development.
Université libre de Bruxelles has added a fourth Theodorus fund to its arsenal with an initial close of $23m and a target of up to $33.5m.
The UCL Technology Fund is in line for an exit from gene therapy developer Orchard Therapeutics, which has raised more than $290m in equity funding.
Oxford regenerative medicine spinout OxStem, which raised $24.4m in 2016, has launched two subsidiaries to focus on therapies for diabetes, chronic inflammation and wound healing.
KIT-founded valve actuator manufacturer Memetis has received capital from the university and HTGF to help expand development and production.
Advanced battery developer Aceleron, which operates from Birmingham and Brunel universities, has been backed by the Midlands Engine Investment Fund.